Thirty-five-week-old MC4R mice were randomly divided into four groups with no blinding at one day before drug treatment, vehicle (saline, s.c.), semaglutide (0.5 mg/kg, s.c.), tirzepatide (0.05 mg/kg, s.c.), and retatrutide (0.05 mg/kg, s.c.) based on amounts of food intake from day 25 before drug treatment, body weight at day 2 before treatment, and fat mass at one day before treatment
For personalized dosage, consult your healthcare provider
Baclofen for the treatment of alcohol use disorder in patients with liver cirrhosis: 10 years after the first evidence
At Elive Health, our typical customer is tech-savvy, values data-driven insights, and prioritizes holistic health aspects such as mindset, exercise, sleep, hormones, nutrition, and gut health